Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sellers remorse is sinking in after the recent news concerning the endpoints. This remorse leads you to bitterness and shows that you have never really believed in this technology hence the quick sell in the 60's.
It will take one big buyer to enter the fray over the next couple of days to end the short resistance. It looks like the news will make its biggest impact next week and who knows NWBO may decide to update the trial next week as well now that the cat is out of the bag.
Here is my take on Imagine as it relates to NWBO.
Imagine there's no cancer
It isn't hard to do
Nothing to kill us or fight us
And no chemicals, too
Imagine all the people
Living life in peace
You, you may say I'm a dreamer
But I'm not the only one
I hope someday you will join us
And the world will be as one
Imagine no diseases
I wonder if you can
No need for grief or sadness
A brotherhood of man
Imagine…
I have sat back and let this latest bit of news sink in. As I sit here I feel a tremendous amount of relief not only for all of us on this board who have chosen to follow this little gem of a company but for all those souls who will benefit from immunotherapy.
On this day in 1971 John Lennon released his single "Imagine" and I cannot think of a more appropriate song to listen to as I contemplate the future of this therapy and the tremendous impact it will have on so many lives. We will indeed all be touched by this therapy and as pioneer shareholders will remember this fight with fondness.
Another event that happened on this day in 1480 is also appropriate.
The Great Stand on the Ugra River where Ivan III Grand Prince of all Russia held his ground against the forces of Akhmat Khan, Khan of the Great Horde, that led to the Mongols retreat and the eventual disintegration of the Horde.
I am looking forward to the disintegration of the fudsters that have plagued this board and congratulate all the longs that have played their part in holding the ground for so long in the name of a beautiful science.
Go NWBO.
Maybe the mad tin cap scientist is leading his merry bunch of acolytes up a steep road to the edge of a cliff. Depending on topline those acolytes may soon realize that a company that provides real life 3/4 and 5 year data is far more valuable than a company that has never made those numbers public. There failure to provide these numbers is the real truth behind their science and I believe will be the inevitable undoing of there technology and in the end Novacure as a serious player in the oncology space. The Acolytes will see themselves turn into lemmings as they tumble over the cliff if immunotherapy becomes the chosen science.
You can only say I told you so once the datalock timeframe has fully played out. The 4 week timeframe leading up to TLD has barely begun. What will be interesting is 2 to 3 weeks from now when the company have been unblinded and no news of failure. Bets are sure to be placed leading up to topline so your brave assertion that nothing will happen is again pure speculation and not based on facts. The facts of the next 4 weeks have barely begun.
I do not think LP cares about the shorts and all NWBO are now concentrating on is achieving TLD. The results are what will define this technology and ultimately the valuation. The shorts will live and die by how reckless they are leading up to TLD. Once the reality of how important the step of achieving Data Lock is and what this means to achieving Positive TLD will soon start to make a positive impact on the share price. The company has worked tirelessly with a wealth of experts to get to this stage. We are now in the final phase leading up to TLD and this in itself will not be long as every I has been dotted and every t crossed to make sure that the data is as solid as it can ever be. We are on the verge of welcoming a paradigm shift in cancer treatment and when this reality hits the market we will wake up to an explosion.
I agree with you 100%, I was just answering a question as to why the SP is not reacting as he would have liked. The outline of the PR is the reason. I too think that a lot more is going on behind the scenes and not overly concerned about current state of the company.
This statement in the PR is an answer to your question.
"With the database now locked, the independent service firms managing the Clinical Trial are arranging for the independent statisticians to have access to the unblinded raw data from the Trial"
How long will it take to do this step as it apparently took from Aug 19th until yesterday to do this as stated on Aug 19th.
Quote "final quality control checking and confirmation are under way to enable Data Lock."
Until the company officially states that work has begun on TLD analysis we are no closer to the end than we were on Aug 19th.
Is this by design, who knows.
You should ask the question of what would make the CEO inform a conference that TLD was expected by end of September yet she made this statement knowing that Data Lock had not yet been achieved or even given to statisticians as of yesterday. Yesterdays PR was an appeasement at best but does not guarantee that work towards TLD has even started.
If the company were forthright then a timeline to TLD would have been expected along with a hard data lock and assurance that work had begun on the data. We are still very much in the dark as to when TLD will actually occur.
This may be all part of some elaborate plan because the communication has definitely reverted back to type and is designed once again to confound.
Most that post on this board have been invested with this company for years and some a decade or more. This board has provided a wealth of information to help any investor achieve a confidence in the science that this company is trying to achieve and present to the world. We are on the brink of TLD and just because a vague date was not achieved should not be used as fuel for negativity. We are in the final days of a decade long trial and this in itself is a miracle for a company that has had to endure the amount of mud thrown at it. We as long term investors need to remain steadfast behind management at this critical stage and should not let the fudsters get under our skin. Our victory will be witnessing a paradigm shift in cancer care and knowing that we as investors represent a microscopic set of individuals who had the good fortune to unearth such a rare gem. Stay strong and stay positive. NWBO and DCVAX is about to be revealed to the world and what a day that will be.
Except that the 9/23 video was definitely recorded at the same time as the 9/08 interview which would indicate a different message. If you watch both videos his appearance is identical.
I have a feeling that the LES interview was all pre-recorded and the short positions were taken up with the knowledge that those 2 clowns were going to release this interview that conflicts with the communications made by the company. Looks like an organized short attack on a nicely appreciated price. Easy money for those fools but I suspect no one will be able to prove such shenanigans. However the company should at least provide additional communication that clarifies the position with regard TLD.
Here is the important line which suggests that this is all done at the same time.
Quote:
I will flag, right from the beginning, we’re very excited because just in the next couple weeks, later this month of September, we will be expecting to unblind, unveil, and announce, finally, the results of our thirteen year long phase three trial of DCVax for glioblastoma brain cancer.
This one line indicates that the trial is unblinded based on their earlier timelines if they intend to announce results at the same time as announcing that they are unblinded.
Your message to the board completely goes against what the company has been relaying to the public and you have to state clearly to this board that your thoughts are purely an opinion and not tied to the company directly. The current falloff in SP is a direct result of the FUD surrounding LES's latest appearance and your subsequent messages supporting the delay as portrayed by Les. We were told to wait for a new line portraying further delays by prominent posters on this board and you have gone ahead and provided that. So is this by design?
So what you are relaying is an opinion and not based on any real information from the company because it seems that many on this board believe you have a line into the company.
It seems your posts have caused a lot of panic on this board because of the credibility you have. Not sure where you get information from but if you admit that you know as little as everyone else on this board some may calm down.
Agree Sojo, when TLD hits and proves to be stunning the left hand side of the chart will be exceeded especially if that silent elephant in the room reveals themselves at the same time.
Funny thing here is that the only job you have on IHUB is too continually pound this company. That in itself should be a massive tell too any new investor. You and your ilk are sad individuals that ply their trade off destroying promising companies and stealing their tech. My fantasy is to see individuals such as you choke on humble pie while knocking back that grapefruit juice by the gallon. I wonder if AF will bake that pie for you as well as squeeze the grapefruits.
The main contingency has always been manufacturing and the ability for DCVAX products to ramp up production ability to cover far more than just GBM. The whale in the room made sure that LP pursued this piece of the puzzle which was just put in place a few weeks ago. Now the whale can look to jump on board and move this product along with their very own into the next phase and that is to tackle all operable and then in-operable cancers.
You just have to go back a few years when you and your buddies ridiculed LP for pleading for help as ASCO regarding manufacturing. Now if you just sit back and think about that for a minute then you may come up with an answer. For me there was a contingency to an agreed partnership based on improving manufacturing before final signoff.
We have had a period of deafening silence that has exasperated many of us but that has all been by design while LP has waited for the technology to catch up.
Well now it has caught up but it seems that you and your buddies have been left in the dark ages with your Avastin and tin cap answers. Good luck with that because soon you will understand the full picture and for all of us it will be a truly beautiful picture.
I also think that the 2 weeks required after receiving data from statisticians allows for partnership talks with the whale we think has been pulling the strings in the background for some time now. How good the results are will denote how big a partnership is announced. We have seen some terrific news lately and the recent buyout of a cutting edge company should have been confirmation to any detractors that the game is up. This acquisition I believe is part of a contingency made some time ago in relation to manufacturing ability. We shall see but the next 2 weeks should reveal the strategy.
This is a classic pump before the dump if NWBO TLD comes out highly positive. The current NVCR price will be cut drastically and is a great put option for anyone into that kind of a trade.
Positive NWBO results would signal the death knoll of this highly dubious technology and is one reason so much FUD is thrown at this board along with the supporters of Avastin which one of our very long term fudsters has never been able to spell correctly.
You need to get a couple of drum sticks so you can turn your tin caps into a drum kit. Your continual pestering on this board will turn into posturing for your beloved Stupp.
And ironically the following was revealed at this particular conference.
The outstanding show-stealer of the entire conference was, however, the outstanding data presented by Roger Stupp on behalf of his collaborators of the innovative EF-14 trial.[8] This was a late breaking abstract and based on an interim analysis, which had been just approved by an independent data safety and monitoring committee.
Many of the fudsters on this board are supporters of this supposed treatment and Dr. Stupp's final slide which was “A new cancer therapy has been born.”
Maybe this coming SNO will be the revelation to the world that an actual cancer therapy that benefits patients through proven survival will be the talk of the town.
You obviously do not want to respond to Sentiment's follow up to Hypers biomarker post and continue to assert your nonsense of years and multiple trials. Maybe a bit more DD on your part would prevent you spouting off your mouth so quickly. There is a reason LP talks about all operable cancers and she is not talking about years and years of additional trials. Maybe all the time that we have been waiting for approval the scientific minds behind DCVAX have been pursuing biomarker tests.
The laughable group of buffoons is back peddling their grape fruit juice theories. Keep the comedy rolling because we all need a good laugh.
Allowing emotions to control your investing is a sure fire way to get burnt big time. Investing very early in Biotechs is not for newbie investors with shallow pockets.
What is transpiring here seems very obvious and if you are still acting on emotions when investing you will continue to get burned, so why waste your time here if you have no intention of climbing back on board.
Yup, and I would not be surprised if you were part and parcel to the Clay short the news club here on the OTC. Maybe this time we will witness a classic reversal of fortune for the longs and NWBO surprise us at the bell with an unexpected news flash. IMO
A true pump and dump will be if NWBO come up with a financing tomorrow evening after another huge down day announcing 30 million shares at 34c per share plus warrants. We would then see the news release as an exercise to pump the share price for their notable inside buyers who then go ahead and sell to unsuspecting retail at 100% profit and at the same time short the shares to then try and profit on both ends. This type of manipulation would then need to be investigated by the SEC as it would clearly indicate an inside manipulation of sort.
If however the buying was genuinely spurred on by the news what we have just witnessed is a classic manipulation of the news by MM's and short sellers who always then take advantage of a slow down to quickly depress the price to induce panic selling by new investors so they can cover the short positions they took out as they let the price run. Again this type of manipulation should be investigated by the SEC but alas it never is.
Tomorrow will tell the story and my belief is that MM's and short sellers will take down the price to a selected target probably 47 as insinuated by jdheart who appears to be a swing trader himself.
The only thing that can prevent the continued manipulation down to a target price would be another news release which would induce covering depending on the type of news released.
We shall see what happens tomorrow but I suspect a downturn on price based on tiny volume compared to what we have witnessed these past few days.
Every share should be considered a golden nugget and selling them for copper pennies at this time would not be a wise move.
I think that LP presented a number and was told that manufacturing was a stickler in that presentation. She has been working to solve that issue hence the delay in the reveal of TLD imo. Nothing is left to do now but reveal and partner/sell.
As Flip and I have pondered in the past there is a background behemoth quietly pulling the strings that has demanded discretion. Now is the time to outline the plan that leads to eventual partnership/buyout and this bombshell announcement that covers manufacturing ability for the masses would very much fit into those plans. It looks too me that Sawston will be a blueprint model that can be replicated 100 fold by a Merck. We are on the cusp of the big reveal and TLD will be an announcement to the world that immunotherapy as a treatment for cancer is the new path forward for all cancer treatment.
Wishing your friend all the very best in the days ahead and also joining in your wish for a brand new day soon to be revealed to the world in fighting this dreadful disease.
The company are well aware of this Youtube presentation and have reviewed. per DI.
Forgot to add that he is the CEO of EnterTROY Bio that would essentially be in competition with NWBO.
Looks like the doctor has his own trial on newly formed GBM so it would be in his best interest if he "ESSENTIALLY" thinks that the DCVaX-l trial has failed.
If anyone would like direct comments from the good doctor he can be reached on his twitter account, but do not expect any answers.
[url]https://clinicaltrials.gov/ct2/show/NCT02861898
Or maybe they just want more time for pps action between datalock, topline and warrant exercising. This latest offering does not reflect any further extension on current timelines but is a reflection on the delays since initial timelines were calculated and warrant exercising dates issued, they being November. So again the December extension is a reflection of the delays the company has already endured and is required to allow for notable pps action before warrant exercising.
Hi Doc et all,
Once the company receives the data from the statisticians, approx 2 weeks after DL how long would they have to inform investors of trial failure if both endpoints are not met. I seem to remember that this disclosure has to be made within days per SEC reqmt. My thinking is that the company said that they would need to consult over the data for approx 2 weeks before releasing topline, so once the 2 weeks from DL are up and we hear no initial news of trial failure surely greater and greater pressure will be felt by those nefarious forces opposing this technology.
The 4 week timeframe has always interested me and my thinking is that if there is a potential partner moving forward this month gap is the perfect opportunity for both parties to thrash out a deal of some sort.
Here is an interesting page regarding obligations of companies per their investors.
[url]https://westwicke.com/2019/11/keys-to-successful-disclosure-of-clinical-trial-data-and-milestones/
Well said, patience is indeed key and to all those who may keep an eye on this board, some active some passive, know that we few investors out of the billions of souls who inhabit this true miracle of the stars are so very close to watching a new awakening in cancer care that will have such a beautiful impact on extending the lives of so many now and into the future. It is time for so much hope to be realized. Eagerly and patiently awaiting NWBO’s awakening. GLTA.
Having lived the first 35 years throughout Africa and receiving every vaccine under the sun, I can attest that I have hardly ever had a cold never mind the Flu. The years I did live in Europe sporadically during this time I remember many people getting colds and flu's around me but I was unaffected. I have now been in the US for the past 15 years and have never taken a day off work due to cold/flu. Hopefully this remains the case with this strain of corona as well.